Connect with us

Technology

Chandigarh University’s Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies

Published

on

Leading national & global companies like Sun Pharma, GSK, Medtronic India, Serum Institute of India recruit Chandigarh University students

CHANDIGARH, India, July 30, 2026 /PRNewswire/ — The rapid growth of Biotechnology, Pharmaceutical Sciences and allied healthcare fields has triggered a high demand for professionals equipped with specialized knowledge, practical skills and industry exposure. To meet this growing demand, Chandigarh University has integrated experiential learning model into its Biotechnology and Pharmaceutical Sciences programmes with 178 students securing placements and 261 students gaining industry internships in leading pharmaceutical companies, reputed healthcare institutions (hospitals) and life sciences organisations over the past three years.

The University Institute of Biotechnology (UIBT) and University Institute of Pharmaceutical Sciences (UIPS) jointly attracted more than 97 national and multinational companies, healthcare institutions and life sciences organizations including Sun Pharma, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, Serum Institute of India, Bharat Serum and Vaccine Limited, IDS Infotech and Ind-Swift Limited, among others.

Chandigarh University students have also extended their professional footprint beyond India, building careers in the leading international healthcare and pharmaceutical companies in different parts of the world.

Among all premiere companies, IDS Infotech has emerged as the largest recruiter for biotechnology students of CU with eight placement offers while Ind-Swift Limited provided the highest number of job opportunities in the Pharmacy department recruiting 11 students from Chandigarh University.

The University Institute of Biotechnology emerged as the largest contributor to the combined placement performance with 118 students securing placements and 252 students completing internships over the past three years. As many as 65 companies participated in the department’s recruitment process during this period, with 2024-25 emerging as the strongest placement year, when 54 students secured job offers in leading national and international companies.

The students secured job offers from IDS Infotech, Cryoviva Biotech Pvt. Ltd., Bharat Serum and Vaccine Limited, Fitelo India Pvt. Ltd., Mikky Publication Services Pvt. Ltd., Serum Institute of India, Integrated Resources and Macleod Pharmaceutical Ltd among other leading companies. Among these IDS Infotech offered the highest number of job offers which was eight whereas Cryoviva Biotech, Bharat Serum and Vaccine Limited, Fitelo India and Mikky Publication Services offered six job offers each.

At the programme level, MSc Biotechnology recorded the highest number of selections with 59 students securing placements over the three-year period. This was followed by B.Sc. Biotechnology with 27 placements, M.Sc. Industrial Microbiology with 15, M.Sc. Microbiology with 10 and B.Sc. Microbiology with six placements.

The students of Biotechnology and Microbiology secured placements with leading pharmaceutical, biotechnology and healthcare organisations with several graduates receiving attractive salary packages. The highest annual package of ₹8 lakh was secured by students of M.Sc. Biotechnology and M.Sc. Industrial Microbiology in 2023–24 while an M.Sc. Microbiology student secured an annual salary package of ₹7.5 lakh from Wellcove (CGCS Services Inc.) in 2025–26.

The students from University Institute of Pharmaceutical Sciences secured 60 placements and nine industry internships over the past three years.

As many as five students also secured internships with Sun Pharma, one of India’s leading pharmaceutical companies, providing them with valuable industry exposure. The students from the Pharmaceutical Sciences department have secured job placements in top brands such as Ind-Swift Limited, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, ADI Group, Nectar Lifesciences, Psychocare Health and Evalueserve among other leading organisations.

Ind-Swift Limited emerged as the largest recruiter by selecting the highest number of students which was 11. Endo India Par Formulations and Macleods Pharmaceuticals selected five students each while Proelio Technologies and Psychocare Health selected four students each. GlaxoSmithKline (GSK) also recruited three students, while Medtronic India, Mankind Pharma and Centrient Pharmaceuticals provided career opportunities to students from the department.

The department’s placement performance has also been reflected in strong salary packages across programmes. Gehna, a Pharm.D student, secured the highest salary package of ₹9.6 LPA at Karuna Cancer Hospital. Similarly, Ayush Sneh, Atul Chaubey and Armaan, B. Pharmacy students were selected by GlaxoSmithKline (GSK) as Medical Representatives at annual salary packages of ₹7.5 lakh each.

Mandvi Pandey, an M. Pharmacy student, secured a ₹7 lakh annual package as Junior Analyst at Evalueserve. Several students have also secured Quality Assurance and Quality Control roles at Ind-Swift Limited, while others have obtained opportunities in Quality Control and internship-based roles with Macleods Pharmaceuticals and Centrient Pharmaceuticals. Sneha Kumari is working as a Pharmacopoeial Associate at the Indian Pharmacopoeia Commission, Ghaziabad, under the Ministry of Health and Family Welfare, Government of India. Another student of Chandigarh University, Hasan Zubair is serving as Head of the Pharmaceutical Policy Division at the Ministry of Health, Zanzibar, Tanzania. Navpreet Bhullar is working as a Pharmacy Assistant within the healthcare system in Alberta, Canada.

These job placements reflect the diverse career opportunities available to Chandigarh University graduates, with students (graduates) contributing not only to leading private pharmaceutical and healthcare companies but also to national and international public health systems.

The strong placement achievements by students from Chandigarh University are supported by a robust culture of research and innovation. Over the past three years, students have published more than 40 research papers in reputed international journals and publications. Two design patents have been granted, while three patents have been filed. Several students have also qualified CSIR-NET JRF and secured admission to PhD programmes at premier institutions including the Indian Institute of Science (IISc), Bengaluru, IIT Delhi, IIT Roorkee and IIIM Jammu.

The department’s students have also achieved international academic success. Tanish Bhalla was selected for the Erasmus Mundus Joint Master’s Degree in Leading International Vaccinology Education (2024–26). Yashika Hablani secured an opportunity for higher education at the University of Melbourne, Australia, while Vamshi Kadari is working as a Graduate Research Assistant at California State University, Fresno, USA. Ishana Goyal secured admission to the M.Sc. Biotechnology programme at the University of Rome Tor Vergata, Italy.

The entrepreneurial achievements of students have further strengthened Chandigarh University’s reputation as a hub for innovation and entrepreneurship. Vedant Rinwa founded Nutripanda Life Care LLP, while Deepanshi established Nubody&CO. The students have also founded startups including Algazen & Okiss Pvt. Ltd., creating new avenues for innovation and entrepreneurship in the life sciences sector.

About Chandigarh University

Chandigarh University is a NAAC A+ Grade University and QS World Ranked University. This autonomous educational institution is approved by UGC and is located near Chandigarh in the state of Punjab. It is the youngest university in India and the only private university in Punjab to be honoured with A+ Grade by NAAC (National Assessment and Accreditation Council). CU offers more than 109 UG and PG programs in the field of engineering, management, pharmacy, law, architecture, journalism, animation, hotel management, commerce, and others. It has been awarded as The University with Best Placements by WCRC.

Website address: https://www.cuchd.in/

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/chandigarh-universitys-biotechnology–pharmacy-students-secure-178-placements-with-leading-pharmaceutical-and-biotechnology-companies-302839047.html

Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

on

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

on

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

on

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Trending